Tennessee last year spent $48 million on a single drug, Humira — about $62,000 for each of the 775 patients who were covered by its employee health insurance program and receiving the treatment.

Tennessee last year spent $48 million on a single drug, Humira — about $62,000 for each of the 775 patients who were covered by its employee health insurance program and receiving the treatment.

Blue Shield is teaming up with drugmaker Fresenius Kabi and Evio Pharmacy Solutions to purchase a biosimilar for Humira at a transparent net price of $525 per monthly dose.

Humira's patent expired in January 2023, opening the door for lower-cost biosimilars. However, prices haven't decreased as much as expected in a functioning market, limiting widespread adoption.

In 2021, Humira — the blockbuster biologic that has for years been the highest grossing drug in the world — accomplished something that no drug had previously achieved when its global revenues ...

Get the facts on Humira’s dosages. You can also learn how to use the drug, which forms it comes in, and more.

Uses. Humira may be prescribed for Crohn's disease or ulcerative colitis, the two main forms of IBD.Humira is approved for use in adults and in children over the age of six. Humira may reduce ...

A report from the inspector general of HHS examines the latest trends since several biosimilar versions of Humira were launched in the U.S. in 2023.

Blue Shield of California partners with Fresenius Kabi and Evio Pharmacy to cut the cost of Humira's biosimilar to $525 per month, with most members paying $0 out of pocket starting January 2025.

Medicare parts B and D may cover Humira, including home injections and the drug itself in certain cases. Some programs may help with costs. Learn more here.

Medicare parts B and D may cover Humira, including home injections and the drug itself in certain cases. Some programs may help with costs. Learn more here.